Clinical Trial Update: Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating anti-inflammatory and anti-oxidative nutrition in dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Protein-energy Malnutrition

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Hypoalbuminemia, Protein-energy Malnutrition | Phase 3 | Status: COMPLETED